A genetic variant present in nearly half of Americans of European ancestry is linked to greater effectiveness of the smoking cessation medication bupropion (Zyban), according to research by scientists supported by the National Institute on Drug Abuse (NIDA) and the National Cancer Institute (NCI), part of the National Institutes of Health (NIH). [click link for full article]
From: www.medicalnewstoday.com
Tuesday, September 11, 2007
NIH Scientists Demonstrate Genetic Variant Is Linked To Greater Effectiveness Of Smoking Cessation Medication
Subscribe to:
Post Comments (Atom)
![Digitalpoint Geo Tracking [Enabled]](http://geo.digitalpoint.com/a.png)
![PingOmatic AutoDiscovery [Enabled]](http://www.genuineblogger.com/images/chicklet-pingomatic.gif)
![Made with Palestinian Efforts [True]](http://www.genuineblogger.com/images/yapalestinets.gif)
No comments:
Post a Comment